Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.

Pavlovic A, Glavina Durdov M, Capkun V, Jakelic Pitesa J, Bozic Sakic M.

Med Sci Monit. 2016 Jul 5;22:2340-6.

2.

Basal autophagy is pivotal for Hodgkin and Reed-Sternberg cells' survival and growth revealing a new strategy for Hodgkin lymphoma treatment.

Birkenmeier K, Moll K, Newrzela S, Hartmann S, Dröse S, Hansmann ML.

Oncotarget. 2016 Jul 19;7(29):46579-46588. doi: 10.18632/oncotarget.10300.

3.

Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.

Xiao W, Chen WW, Sorbara L, Davies-Hill T, Pittaluga S, Raffeld M, Jaffe ES.

Hum Pathol. 2016 Sep;55:108-16. doi: 10.1016/j.humpath.2016.04.019. Epub 2016 May 14.

PMID:
27184478
4.

K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.

Steinbrück L, Gustems M, Medele S, Schulz TF, Lutter D, Hammerschmidt W.

J Virol. 2015 Jul;89(14):7248-61. doi: 10.1128/JVI.00839-15. Epub 2015 May 6.

6.
7.

Epstein-Barr virus and Burkitt lymphoma.

Rowe M, Fitzsimmons L, Bell AI.

Chin J Cancer. 2014 Dec;33(12):609-19. doi: 10.5732/cjc.014.10190. Epub 2014 Nov 21. Review.

8.
9.

Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology.

Goldenberg DM, Gold DV, Loo M, Liu D, Chang CH, Jaffe ES.

PLoS One. 2013;8(2):e55324. doi: 10.1371/journal.pone.0055324. Epub 2013 Feb 6.

10.

Hodgkin lymphoma.

Küppers R, Engert A, Hansmann ML.

J Clin Invest. 2012 Oct;122(10):3439-47. doi: 10.1172/JCI61245. Epub 2012 Oct 1. Review.

11.

Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma.

Renné C, Benz AH, Hansmann ML.

BMC Cancer. 2012 Jun 6;12:215. doi: 10.1186/1471-2407-12-215.

12.

Soluble factors produced by activated CD4+ T cells modulate EBV latency.

Nagy N, Adori M, Rasul A, Heuts F, Salamon D, Ujvári D, Madapura HS, Leveau B, Klein G, Klein E.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1512-7. doi: 10.1073/pnas.1120587109. Epub 2012 Jan 17.

13.

Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010.

Gopal S, Martin KE, Richards KL, Eron JJ.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):798-805. doi: 10.1089/AID.2011.0259. Epub 2011 Dec 1.

14.

Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study.

Kasperzyk JL, Chang ET, Birmann BM, Kraft P, Zheng T, Mueller NE.

Am J Epidemiol. 2011 Oct 1;174(7):816-27. doi: 10.1093/aje/kwr190. Epub 2011 Aug 1.

15.

EBV in Hodgkin Lymphoma.

Massini G, Siemer D, Hohaus S.

Mediterr J Hematol Infect Dis. 2009 Nov 24;1(2):e2009013. doi: 10.4084/MJHID.2009.013.

16.

Hodgkin disease and the role of the immune system.

Kennedy-Nasser AA, Hanley P, Bollard CM.

Pediatr Hematol Oncol. 2011 Apr;28(3):176-86. doi: 10.3109/08880018.2011.557261. Review.

17.
18.

Clinical, molecular, and environmental risk factors for hodgkin lymphoma.

Maggioncalda A, Malik N, Shenoy P, Smith M, Sinha R, Flowers CR.

Adv Hematol. 2011;2011:736261. doi: 10.1155/2011/736261. Epub 2010 Nov 29.

19.

Multiplexed detection and characterization of rare tumor cells in Hodgkin's lymphoma with multicolor quantum dots.

Liu J, Lau SK, Varma VA, Kairdolf BA, Nie S.

Anal Chem. 2010 Jul 15;82(14):6237-43. doi: 10.1021/ac101065b.

20.

Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.

Gulley ML, Tang W.

Clin Microbiol Rev. 2010 Apr;23(2):350-66. doi: 10.1128/CMR.00006-09. Review.

Supplemental Content

Support Center